Urocortin II (Human)


Catalog #
019-30 100 µg $167

Sequence:  ()
  • Molecular Weight:
  • 4153.93
  • Purity:
  • ≥ 95%
  • Validation:
  • Exhibits correct molecular weight
  • Solubility:
  • Insoluble in water.
    Dissolve in a small amount of DMSO or 60% acetonitrile in water with 0.1% TFA. Then dilute with water or any desired buffer.
  • Storage:
  • Up to 6 months in lyophilized form at 0-5°C.
    For best results, rehydrate just before use.
    After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
  • Appearance:
  • White powder
  • Contents:
  • Each vial contains 100 µg of NET peptide.
  • MSDS:
  • View/Download(PDF)

Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P, Reis FM, Torres PB, et al. Obstet Gynecol. 2007;110(3):594-600.

Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N. Pharmacol Biochem Behav. 2006;85(2):435-40.

High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P, Torricelli M, De falco G, et al. J Hypertens. 2006;24(9):1831-40.

Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies.
Torricelli M, Ignacchiti E, Giovannelli A, et al. Eur J Endocrinol. 2006;154(2):281-5.

High fetal urocortin levels at term and preterm labor.
Florio P, Torricelli M, Galleri L, et al. J Clin Endocrinol Metab. 2005;90(9):5361-5.

Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells.
Aggelidou E, Hillhouse EW, Grammatopoulos DK. Proc Natl Acad Sci USA. 2002;99(5):3300-5.

Related Products

Catalog# Product Size Price Buy Now